216 related articles for article (PubMed ID: 34713106)
1. Personalised, Rational, Efficacy-Driven Cancer Drug Dosing
Tan BKJ; Teo CB; Tadeo X; Peng S; Soh HPL; Du SX; Luo VWY; Bandla A; Sundar R; Ho D; Kee TW; Blasiak A
Front Digit Health; 2021; 3():635524. PubMed ID: 34713106
[No Abstract] [Full Text] [Related]
2. CURATE.AI-assisted dose titration for anti-hypertensive personalized therapy: study protocol for a multi-arm, randomized, pilot feasibility trial using CURATE.AI (CURATE.AI ADAPT trial).
Truong ATL; Tan SB; Wang GZ; Yip AWJ; Egermark M; Yeung W; Lee VV; Chan MY; Kumar KS; Tan LWJ; Vijayakumar S; Blasiak A; Wang LYT; Ho D
Eur Heart J Digit Health; 2024 Jan; 5(1):41-49. PubMed ID: 38264697
[TBL] [Abstract][Full Text] [Related]
3. CURATE.AI COR-Tx platform as a digital therapy and digital diagnostic for cognitive function in patients with brain tumour postradiotherapy treatment: protocol for a prospective mixed-methods feasibility clinical trial.
Remus A; Tadeo X; Kai GNS; Blasiak A; Kee T; Vijayakumar S; Nguyen L; Raczkowska MN; Chai QY; Aliyah F; Rusalovski Y; Teo K; Yeo TT; Wong ALA; Chia D; Asplund CL; Ho D; Vellayappan BA
BMJ Open; 2023 Oct; 13(10):e077219. PubMed ID: 37879700
[TBL] [Abstract][Full Text] [Related]
4. Personalised Dosing Using the CURATE.AI Algorithm: Protocol for a Feasibility Study in Patients with Hypertension and Type II Diabetes Mellitus.
Mukhopadhyay A; Sumner J; Ling LH; Quek RHC; Tan ATH; Teng GG; Seetharaman SK; Gollamudi SPK; Ho D; Motani M
Int J Environ Res Public Health; 2022 Jul; 19(15):. PubMed ID: 35897349
[TBL] [Abstract][Full Text] [Related]
5. Physicians' Perspectives on AI in Clinical Decision Support Systems: Interview Study of the CURATE.AI Personalized Dose Optimization Platform.
Vijayakumar S; Lee VV; Leong QY; Hong SJ; Blasiak A; Ho D
JMIR Hum Factors; 2023 Oct; 10():e48476. PubMed ID: 37902825
[TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
7. LUMOS - Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS at relapse: Protocol for a pilot study.
Kong BY; Sim HW; Nowak AK; Yip S; Barnes EH; Day BW; Buckland ME; Verhaak R; Johns T; Robinson C; Thomas MA; Giardina T; Lwin Z; Scott AM; Parkinson J; Jeffree R; Lourenco RA; Hovey EJ; Cher LM; Kichendasse G; Khasraw M; Hall M; Tu E; Amanuel B; Koh ES; Gan HK
BMJ Open; 2021 Dec; 11(12):e054075. PubMed ID: 37185327
[TBL] [Abstract][Full Text] [Related]
8. CONFIDENT-trial protocol: a pragmatic template for clinical implementation of artificial intelligence assistance in pathology.
Flach RN; Stathonikos N; Nguyen TQ; Ter Hoeve ND; van Diest PJ; van Dooijeweert C
BMJ Open; 2023 Jun; 13(6):e067437. PubMed ID: 37286323
[TBL] [Abstract][Full Text] [Related]
9. Use of an electronic patient-reported outcome measure in the management of patients with advanced chronic kidney disease: the RePROM pilot trial protocol.
Kyte D; Bishop J; Brettell E; Calvert M; Cockwell P; Dutton M; Eddington H; Hadley G; Ives NJ; Jackson LJ; Stringer S; Valente M
BMJ Open; 2018 Oct; 8(10):e026080. PubMed ID: 30373785
[TBL] [Abstract][Full Text] [Related]
10. Ontario Brain Injury Association Peer Support Program: a mixed methods protocol for a pilot randomised controlled trial.
Munce SEP; Jaglal S; Kastner M; Nelson MLA; Salbach NM; Shepherd J; Sweet SN; Wilcock R; Thoms C; Bayley MT
BMJ Open; 2019 Mar; 9(3):e023367. PubMed ID: 30904839
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocol.
Clark E; Morton M; Sharma S; Fisher H; Howel D; Walker J; Wood R; Hancock H; Maier R; Marshall J; Bahl A; Crabb S; Jain S; Pedley I; Jones R; Staffurth J; Heer R
BMJ Open; 2019 Dec; 9(12):e034708. PubMed ID: 31857319
[TBL] [Abstract][Full Text] [Related]
12. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
Drugs R D; 2005; 6(3):178-85. PubMed ID: 15869322
[TBL] [Abstract][Full Text] [Related]
13. Artificial intelligence and its potential in oncology.
Londhe VY; Bhasin B
Drug Discov Today; 2019 Jan; 24(1):228-232. PubMed ID: 30342246
[TBL] [Abstract][Full Text] [Related]
14. CURATE.AI: Optimizing Personalized Medicine with Artificial Intelligence.
Blasiak A; Khong J; Kee T
SLAS Technol; 2020 Apr; 25(2):95-105. PubMed ID: 31771394
[TBL] [Abstract][Full Text] [Related]
15. Protocol for a pilot randomised controlled trial of an educational programme for adults on chronic haemodialysis with fatigue (Fatigue-HD).
Farragher JF; Thomas C; Ravani P; Manns B; Elliott MJ; Hemmelgarn BR
BMJ Open; 2019 Jul; 9(7):e030333. PubMed ID: 31366664
[TBL] [Abstract][Full Text] [Related]
16. Trabectedin: Ecteinascidin 743, Ecteinascidin-743, ET 743, ET-743, NSC 684766.
Drugs R D; 2006; 7(5):317-28. PubMed ID: 16922593
[TBL] [Abstract][Full Text] [Related]
17. A pilot, quasi-experimental, mixed methods investigation into the efficacy of a group psychotherapy intervention for caregivers of outpatients with cancer: the COPE study protocol.
Mahendran R; Tan JY; Griva K; Lim HA; Ng HY; Chua J; Lim SE; Kua EH
BMJ Open; 2015 Nov; 5(11):e008527. PubMed ID: 26586322
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a personalised adherence intervention to improve photoprotection in adults with Xeroderma Pigmentosum (XP): protocol for the trial of XPAND.
Walburn J; Norton S; Sarkany R; Sainsbury K; Araújo-Soares V; Morgan M; Canfield M; Foster L; Heydenreich J; McCrone P; Mander A; Sniehotta FF; Wulf HC; Weinman J
BMJ Open; 2019 Jul; 9(7):e028577. PubMed ID: 31320353
[TBL] [Abstract][Full Text] [Related]
19. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
Adis International Ltd
Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
[TBL] [Abstract][Full Text] [Related]
20. A pilot randomised controlled trial of personalised care after treatment for prostate cancer (TOPCAT-P): nurse-led holistic-needs assessment and individualised psychoeducational intervention: study protocol.
Stanciu MA; Morris C; Makin M; Watson E; Bulger J; Evans R; Hiscock J; Hoare Z; Edwards RT; Neal RD; Wilkinson C
BMJ Open; 2015 Jun; 5(6):e008470. PubMed ID: 26112224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
